Quest Diagnostics Highlights Q4 Testing Volume Growth and Reaffirms FY26 Guidance
Quest Diagnostics held its fourth-quarter earnings call on February 11, during which management discussed trends in diagnostic testing volumes and implementation of cost-control initiatives. Executives reaffirmed full-year 2026 revenue and adjusted EPS guidance and outlined planned investments in lab network optimization.
1. Q4 Earnings Call Overview
On February 11, Quest Diagnostics hosted its Q4 earnings call, with management reviewing diagnostic testing volume trends and recent operational performance. Executives highlighted initiatives to streamline costs and enhance service delivery across the company’s lab network.
2. Fiscal 2026 Outlook
During the call, leadership reaffirmed the company’s full-year 2026 revenue and adjusted EPS guidance ranges, emphasizing stable demand for core testing services. The team also outlined planned investments in laboratory expansion and technology upgrades to support future growth.